HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amniotic septostomy for the treatment of twin oligohydramnios-polyhydramnios sequence.

AbstractOBJECTIVE:
To report our experience with intentional puncture of the intervening membrane ('septostomy') for the treatment of the twin oligohydramnios-polyhydramnios sequence (TOPS).
METHODS:
12 patients were diagnosed with TOPS based on ultrasonographic findings. A 20- to 22-gauge spinal needle was used to puncture the membrane between the twins without any attempt at amnioreduction in 9 patients, while the procedure was combined with amnioreductions in 3 patients.
RESULTS:
Gestational age was 23.1 +/- 3.3 weeks at the time of septostomy and 31.1 +/- 4.4 weeks at delivery. Rapid accumulation of fluid around the 'stuck' fetus occurred in all cases following a single procedure. Three of the 24 fetuses died in utero and 1 died on the fifth day of life, for a combined survival of 83.3%. In the survivors, the septostomy to delivery interval ranged between 0.6 and 13 weeks (mean +/- SD 8.3 +/- 4.8).
CONCLUSION:
Amniotic septostomy is a promising new method for the management of TOPS and is associated with survival rates that are better than, or comparable to, more invasive modalities. A multicenter trial comparing septostomy to other modalities is warranted.
AuthorsG R Saade, M A Belfort, D L Berry, T H Bui, L D Montgomery, A Johnson, M O'Day, G L Olson, H Lindholm, L Garoff, K J Moise Jr
JournalFetal diagnosis and therapy (Fetal Diagn Ther) 1998 Mar-Apr Vol. 13 Issue 2 Pg. 86-93 ISSN: 1015-3837 [Print] Switzerland
PMID9650653 (Publication Type: Journal Article)
Topics
  • Amnion (surgery)
  • Diseases in Twins
  • Female
  • Fetal Death
  • Fetofetal Transfusion (diagnostic imaging, surgery)
  • Gestational Age
  • Humans
  • Oligohydramnios (surgery)
  • Polyhydramnios (surgery)
  • Pregnancy
  • Pregnancy Outcome
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: